Hepatopulmonary syndrome interventions: Difference between revisions
Created page with "__NOTOC__ {{Hepatopulmonary syndrome}} {{CMG}}; {{AE}} {{Soroush}}" |
No edit summary |
||
| Line 2: | Line 2: | ||
{{Hepatopulmonary syndrome}} | {{Hepatopulmonary syndrome}} | ||
{{CMG}}; {{AE}} {{Soroush}} | {{CMG}}; {{AE}} {{Soroush}} | ||
==Overview== | |||
There are no recommended therapeutic interventions for the management of hepatopulmonary syndrome. | |||
OR | |||
[Name of intervention] is not the first-line treatment option for patients with hepatopulmonary syndrome. [Name of intervention] is usually reserved for patients with either [indication 1], [indication 2], and [indication 3] | |||
OR | |||
The mainstay of treatment for hepatopulmonary syndrome is medical therapy/surgery. [Name of intervention] is usually reserved for patients with either [indication 1], [indication 2], and/or [indication 3]. | |||
OR | |||
The feasibility of [name of intervention] depends on the stage of [disease or malignancy] at the time of diagnosis. | |||
OR | |||
[Name of intervention] is the mainstay of treatment for [disease or malignancy]. | |||
==Indications== | |||
The mainstay of treatment for TT is medical therapy. | |||
==References== | |||
{{Reflist|2}} | |||
{{WH}} | |||
{{WS}} | |||
[[Category: (name of the system)]] | |||
Revision as of 21:26, 3 July 2019
|
Hepatopulmonary syndrome Microchapters |
|
Differentiating Hepatopulmonary syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Hepatopulmonary syndrome interventions On the Web |
|
American Roentgen Ray Society Images of Hepatopulmonary syndrome interventions |
|
Risk calculators and risk factors for Hepatopulmonary syndrome interventions |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Soroush Seifirad, M.D.[2]
Overview
There are no recommended therapeutic interventions for the management of hepatopulmonary syndrome.
OR
[Name of intervention] is not the first-line treatment option for patients with hepatopulmonary syndrome. [Name of intervention] is usually reserved for patients with either [indication 1], [indication 2], and [indication 3]
OR
The mainstay of treatment for hepatopulmonary syndrome is medical therapy/surgery. [Name of intervention] is usually reserved for patients with either [indication 1], [indication 2], and/or [indication 3].
OR
The feasibility of [name of intervention] depends on the stage of [disease or malignancy] at the time of diagnosis.
OR
[Name of intervention] is the mainstay of treatment for [disease or malignancy].
Indications
The mainstay of treatment for TT is medical therapy.